Lacosamide 65862-0747
Product NDC
65862-0747- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- January 5, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA204994
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 50 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(2)
3 BLISTER PACK in 1 CARTON (65862-747-03) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-747-10)
60 TABLET, FILM COATED in 1 BOTTLE (65862-747-60)